Stryker Co. (NYSE:SYK) Shares Bought by L. Roy Papp & Associates LLP

L. Roy Papp & Associates LLP grew its position in shares of Stryker Co. (NYSE:SYK) by 1.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 63,255 shares of the medical technology company’s stock after purchasing an additional 969 shares during the quarter. Stryker accounts for 2.4% of L. Roy Papp & Associates LLP’s holdings, making the stock its 13th largest holding. L. Roy Papp & Associates LLP’s holdings in Stryker were worth $18,942,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Keybank National Association OH boosted its position in shares of Stryker by 3.5% in the third quarter. Keybank National Association OH now owns 27,823 shares of the medical technology company’s stock worth $7,603,000 after acquiring an additional 952 shares during the last quarter. CoreCap Advisors LLC boosted its position in shares of Stryker by 3.9% in the fourth quarter. CoreCap Advisors LLC now owns 5,030 shares of the medical technology company’s stock worth $1,506,000 after acquiring an additional 191 shares during the last quarter. DNB Asset Management AS boosted its position in shares of Stryker by 5.7% in the fourth quarter. DNB Asset Management AS now owns 76,413 shares of the medical technology company’s stock worth $22,883,000 after acquiring an additional 4,143 shares during the last quarter. Hunter Perkins Capital Management LLC boosted its position in shares of Stryker by 50.6% in the fourth quarter. Hunter Perkins Capital Management LLC now owns 9,595 shares of the medical technology company’s stock worth $2,879,000 after acquiring an additional 3,225 shares during the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC acquired a new stake in shares of Stryker in the third quarter worth approximately $30,365,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the sale, the chief accounting officer now owns 3,675 shares in the company, valued at $1,317,414. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the sale, the chief accounting officer now owns 3,675 shares in the company, valued at $1,317,414. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 201,146 shares of the business’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $342.90, for a total transaction of $68,972,963.40. Following the transaction, the director now directly owns 3,755,128 shares of the company’s stock, valued at approximately $1,287,633,391.20. The disclosure for this sale can be found here. Insiders sold a total of 212,109 shares of company stock worth $72,845,768 over the last 90 days. Insiders own 5.90% of the company’s stock.

Analyst Ratings Changes

SYK has been the topic of a number of recent research reports. Canaccord Genuity Group raised shares of Stryker from a “hold” rating to a “buy” rating and lifted their price target for the company from $315.00 to $360.00 in a research report on Wednesday, January 31st. Wells Fargo & Company lifted their price target on shares of Stryker from $336.00 to $364.00 and gave the company an “overweight” rating in a research report on Wednesday, January 31st. Morgan Stanley lifted their price target on shares of Stryker from $300.00 to $320.00 and gave the company an “equal weight” rating in a research report on Monday, December 4th. Truist Financial lifted their price target on shares of Stryker from $330.00 to $345.00 and gave the company a “hold” rating in a research report on Wednesday, January 31st. Finally, Roth Mkm lifted their price objective on shares of Stryker from $345.00 to $348.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $331.52.

Stryker Stock Down 0.2 %

Shares of NYSE:SYK traded down $0.84 during midday trading on Friday, reaching $357.87. The company had a trading volume of 1,074,753 shares, compared to its average volume of 1,130,776. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.97. The stock’s fifty day moving average price is $344.28 and its 200-day moving average price is $305.97. The stock has a market capitalization of $136.16 billion, a P/E ratio of 43.38, a PEG ratio of 2.92 and a beta of 0.89. Stryker Co. has a one year low of $249.98 and a one year high of $361.41.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.27 by $0.19. Stryker had a net margin of 15.44% and a return on equity of 22.99%. The business had revenue of $5.82 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same quarter in the previous year, the firm earned $3.00 earnings per share. The business’s revenue was up 11.8% compared to the same quarter last year. Equities research analysts expect that Stryker Co. will post 11.86 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Friday, March 29th will be paid a dividend of $0.80 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.20 annualized dividend and a yield of 0.89%. Stryker’s payout ratio is 38.79%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.